Se. Nagyagren et al., ZYGOMYCOSIS (MUCORMYCOSIS) AND HIV-INFECTION - REPORT OF 3 CASES AND REVIEW, Journal of acquired immune deficiency syndromes and human retrovirology, 10(4), 1995, pp. 441-449
We report three cases of zygomycosis (mucormycosis) occurring in three
individuals infected with the human immunodeficiency virus (HIV) and
review 12 other published cases. We present the only two case reports
of disseminated zygomycosis in AIDS patients, and the only AIDS patien
t with renal zygomycosis to survive without nephrectomy, receiving int
ravenous (i.v.) amphotericin alone. Coinfection with zygomycosis and H
IV is rare, occurs primarily in patients with low CD4(+) lymphocyte co
unts, does not always require the usual predisposing conditions for zy
gomycosis, and may be the presenting opportunistic infection among HIV
-infected persons. Transient episodes of neutropenia occurring within
4 months before presentation may be a risk factor for this disease. Zy
gomycosis may arise in multiple sites including the basal ganglia, cut
aneous tissue, kidney, respiratory tract, and may be disseminated. Occ
urring more commonly in, but not restricted to, injection drug users,
it is significantly associated with sites other than basal ganglia in
those patients with advanced HIV disease or AIDS, The presenting sympt
oms are related to the site of involvement, and the illness may develo
p insidiously or progress rapidly to a fulminant course. Successful th
erapy usually consists of surgical debridement and intravenous amphote
ricin B. Overall mortality in this review is 40%, and is significantly
associated with sites of disease inaccessible to surgical debridement
.